EU agrees deal with Sanofi for COVID-19 vaccine supply

COVID-19 vaccine

The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow the trading bloc’s members to purchase the vaccines if and when it gets an approval.

This is part of a wider strategy the EU is pursuing. They have set aside a fund of $2.4 billion to strike separate deals with multiple pharmaceutical companies developing vaccines to ensure the EU’s 450 million citizens have access to a potential treatment.

Image caption:  Photo by MPD01605

read more

Geen nieuws missen?
Volg de duizenden farma professionals die via e-mail lezen

Uw inschrijving is gelukt.